1. Home
  2. LNTH vs CZR Comparison

LNTH vs CZR Comparison

Compare LNTH & CZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$100.93

Market Cap

6.7B

Sector

Health Care

ML Signal

HOLD

Logo Caesars Entertainment Inc.

CZR

Caesars Entertainment Inc.

HOLD

Current Price

$29.69

Market Cap

6.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNTH
CZR
Founded
1956
1937
Country
United States
United States
Employees
N/A
15500
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.0B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
LNTH
CZR
Price
$100.93
$29.69
Analyst Decision
Buy
Buy
Analyst Count
6
13
Target Price
$87.00
$31.92
AVG Volume (30 Days)
1.6M
3.5M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.91
N/A
Revenue
$343,374,000.00
$1,473,504,000.00
Revenue This Year
N/A
$3.56
Revenue Next Year
$14.19
$2.48
P/E Ratio
$34.65
N/A
Revenue Growth
3.62
65.03
52 Week Low
$49.67
$17.86
52 Week High
$111.86
$30.88

Technical Indicators

Market Signals
Indicator
LNTH
CZR
Relative Strength Index (RSI) 46.25 47.50
Support Level $100.51 $29.52
Resistance Level $102.66 $30.86
Average True Range (ATR) 0.53 0.11
MACD 0.15 -0.01
Stochastic Oscillator 50.86 34.55

Price Performance

Historical Comparison
LNTH
CZR

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

About CZR Caesars Entertainment Inc.

Caesars Entertainment's stand-alone portfolio includes about 50 domestic gaming properties across the Las Vegas (48% of 2025 EBITDAR) and regional (49%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2025. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform. The portfolio is set to expand to more than 60 casinos with the proposed acquisition of Caesars by Fertitta Entertainment and its Golden Nugget resorts.

Share on Social Networks: